Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc van Rompaey

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Biomedicines|July 2, 2021
The NHance<sup>®</sup> Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer PatientsPhilippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
Cancer|November 2, 2021
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphomaNicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, et al.
Nature Biotechnology|October 2, 2002
Arrayed adenoviral expression libraries for functional screeningFrits Michiels, Helmuth van Es, Luc van Rompaey, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Biomedicines|July 2, 2021
The NHance<sup>®</sup> Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer PatientsPhilippe Aftimos, Christian Rolfo, Sylvie Rottey, et al.
Cancer|November 2, 2021
Cusatuzumab for treatment of CD70-positive relapsed or refractory cutaneous T-cell lymphomaNicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, et al.
Nature Biotechnology|October 2, 2002
Arrayed adenoviral expression libraries for functional screeningFrits Michiels, Helmuth van Es, Luc van Rompaey, et al.
Pageof 2